Topics

J&J exits opioid federal trial with $20.4m settlement

09:16 EDT 3 Oct 2019 | in-PharmaTechnologis

Johnson & Johnson reaches $20m settlement with two US counties on lawsuits regarding the opioid crisis, exits the upcoming federal trial involving several drug manufacturers.

Original Article: J&J exits opioid federal trial with $20.4m settlement

NEXT ARTICLE

More From BioPortfolio on "J&J exits opioid federal trial with $20.4m settlement"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...